Concepedia

Tu Wang

TW

4

Publications

47

Citations

4

H-Index

2020

Active since

Affiliations

Chengde Medical University(Current)

Tu Wang is an author at Chengde Medical University specializing in oxidative stress, inflammation, and medicine.

ORCID

Top concepts

Publications per year

2020–2021

4

Publications

4

Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats

Tu Wang, Ya-Qin Xie, Guangxin Miao et al. · Life Sciences · 2020 · 15 citations

, , +14

Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway

Juan Zhao, Guangxin Miao, Tu Wang et al. · Life Sciences · 2020 · 11 citations

, , +9

Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway

Ying Li, Zheming Guo, Haipeng Cui et al. · Molecular Medicine Reports · 2021 · 11 citations · Full text

, , +17

Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway

Tu Wang, Lide Xie, Hongdong Bi et al. · European Journal of Pharmacology · 2021 · 10 citations

Rows per page

1–4 of 4